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Transcranial magnetic stimulation (TMS) gives rise to muscle responses, known as
motor evoked potentials (MEP), through activation of the motor pathways. Voluntary
contraction causes facilitation of MEPs, which consists of shortening MEP latency,
increasing MEP amplitude and widening MEP duration. While an increase in excitability
of alpha motorneurons and the corticospinal tract can easily explain latency shortening
and amplitude increase, other mechanisms have to be accounted for to explain the
increase in duration. Wemeasured the increase in duration of the MEP during contraction
with respect to rest in a group of healthy volunteers and retrospectively assessed this
parameter in patients who were examined in a standardized fashion during the past 5
years. We included 25 healthy subjects, 21 patients with multiple sclerosis, 33 patients
with acute stroke, 5 patients with hereditary spastic paraparesis, and 5 patients with
signs suggesting psychogenic paresis. We found already significant differences among
groups in the MEP duration at rest, patients with MS had a significantly longer duration,
and patients with stroke had significantly shorter duration, than the other two groups.
The increase in MEP duration during voluntary contraction was different in patients and
in healthy subjects. It was significantly shorter in MS and significantly longer in stroke
patients. It was absent in the five patients with suspected psychogenic weakness. In
patients with HSP, an abnormally increase in duration occurred only in leg muscles. Our
results suggest that the increase in duration of the MEP during contraction may reveal the
contribution of propriospinal interneurons to the activation of alpha motorneurons. This
mechanism may be altered in some diseases and, therefore, the assessment proposed
in this work may have clinical applicability for the differential diagnosis of weakness.
Keywords: motor evoked potential, contraction-induced facilitation, stroke, multiple sclerosis, spastic
paraparesis, psychogenic weakness
INTRODUCTION
Transcranial magnetic stimulation (TMS) gives rise to muscle responses, known as motor evoked
potentials (MEP), through activation of the motor pathways (Amassian et al., 1987; Day et al., 1987,
1989; Rothwell et al., 1987, 1991). Voluntary contraction causes facilitation of the MEPs, which
consists of shortening the MEP latency, increasing the MEP size and widening the MEP duration
resulting in an increase in total MEP area (Mills et al., 1987; Valls-Solé et al., 1994a,b).While latency
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shortening and amplitude increase can be well explained by
assuming that voluntary contraction put more motorneurons
near the firing threshold, the rationale behind the increase in
MEP duration is less clear. On one side, motorneurons should
be firing earlier and more synchronously to give rise to the
shortening of latency and increase in peak amplitude. However,
MEP duration increases beyond the time that theMEPwould end
if elicited at rest. Therefore, some motorneurons should receive
excitatory inputs with latency longer than at rest. This could be
due to activation of slow conducting corticospinal fibers or to the
generation of excitatory inputs at spinal level (Brasil-Neto et al.,
1992; Di Lazzaro et al., 1999, 2001), but it seems contradictory
that slow conducting corticospinal fibers are recruited during
voluntary contraction. Many sources of inhibition lead to the
silent period after synchronized alpha motorneuron firing.
After hyperpolarization prevents motorneurons from immediate
reactivation and inhibitory inputs from Renshaw cells should
reach the motorneuron within few milliseconds (ms) after the
peak. Even if some inhibitory activity may be temporarily
switched off during contraction, this does not justify the presence
of EMG activity at a time when there are no identifiable excitatory
inputs.
The EMG activity that follows the MEP during contraction
is not usually taken into account in clinical assessment through
TMS. The effects of facilitation are usually evaluated by either
the onset latency or the size of the MEP. Onset of silent
period is usually measured from more stable marks such as
the stimulus artifact or MEP latency onset. We argue that
measuring the characteristics of such segment of EMG activity
might be of some clinical applicability. We reasoned that, when
an MEP is elicited during voluntary contraction, inhibitory
inputs generated at spinal level or by the descending volleys
should counteract the excitatory commands to effectively end
the ongoing EMG activity and give way to the silent period.
This may take some time and, meanwhile, the EMG activity
will not be suppressed. We considered that such “MEPtail,” i.e.,
the EMG activity that follows the MEP peak and ends at the
beginning of the silent period, should indicate the relationship
between the strength of the excitatory inputs reaching the
alpha motorneurons during voluntary contraction and the
inhibitory inputs derived from the synchronized activation of
alpha motorneurons at the time of the MEP. Therefore, we
determined the extent of contraction-induced facilitation of the
MEP in healthy subjects, with special attention to the increase
in MEP duration, and performed a retrospective analysis of how
such parameter was affected in various neurological disorders
involving the motor pathway, i.e., multiple sclerosis (MS),
stroke, hereditary spastic paraparesis (HSP), and psychogenic
weakness.
METHODS
We performed a retrospective study of the recordings obtained
within the last 5 years in healthy subjects and patients in
whom we examined facilitation of the MEP in the first dorsal
interosseous muscle (FDI), using a standardized method. We
included 25 healthy subjects, 21 patients with multiple sclerosis,
33 patients with acute ischemic stroke, 5 patients with hereditary
spastic paraparesis, and 5 patients with the clinical diagnosis
of probable psychogenic paresis. In 12 healthy subjects and in
the 5 patients with hereditary spastic paraparesis, we recorded
the MEP also from the tibialis anterior (TA). The overall
inclusion criteria were to have consistently elicitable MEPs at
rest to cortical stimulation and a complete study carried out
by following the protocol summarized below. Patients with
multiple sclerosis were all diagnosed according to the McDonald
criteria (Polman et al., 2011). They all had signs compatible
with mild to moderate involvement of the motor pathway,
with a mean Expanded Disability Status Scale of 3.5 (range
between 2 and 6) and no one above four for the functional
scale on pyramidal signs (Kurtzke, 1983). Patients with stroke
were examined within the first 2 weeks after presentation of the
lesion and had mild to severe hemiparesis due to a subcortical
ischemic middle cerebral artery infarct. Patients with hereditary
spastic paraparesis were all genetically mediated, spastin positive
(SPG4), each of them belonging to a different family. Patients
with psychogenic weakness had all normal diagnostic tests for
possible lesions in the motor pathway and clinical evidence
of inconsistent weakness, out of proportion of examination
findings.
Retrospective data were all collected following a standardized
protocol, which contemplated recording at rest and during a
voluntary contraction of about 30% of maximum. The stimuli
were applied with a Magstim (Magstim Company, Dyfed, UK),
equipped with either a figure-of-8 coil for hand muscles or
a circular coil for leg muscles. Subjects were sitting, relaxed,
and alert. Silver/silver chloride disk electrodes were used for
recording all responses. They were attached bilaterally, in a
belly-tendon montage, over the FDI for the study of upper
limb muscles, which was done in all subjects, and the TA
for the study of lower limb muscles in healthy subjects and
patients with HSP. EMG signals were filtered and amplified,
and traces were recorded using a KeyPointNet electromyograph.
Stimulus intensity was fixed at about 120% resting motor
threshold, which, based on the recommendations of Rossini
et al. (1994), we determined as the minimum stimulus intensity
that gave rise to a MEP of at least 50µV amplitude in at
least 50% of trials when TMS was applied to the appropriate
scalp location for the target muscle, with the subject at
rest. In all instances, we recorded a variable number of
MEPs at each stimulation condition (between 2 and 10) and
superimposed them at their best fit to facilitate parametric
measuring.
In a group of newly recruited 10 healthy subjects, we examined
again the effects of facilitation on the MEP to cortical stimulation
and added the observation of the effects on the MEP elicited
by cervical foraminal stimulation. We asked these subjects to
perform two different levels of muscle contraction: mild (10%
of maximum voluntary contraction) and strong (30% of their
maximum voluntary contraction). At the time of testing, the
participants signed an informed consent and the study protocol
for retrospective data collection, as well as for the new study in
healthy subjects, were approved by the Ethics committee of the
Hospital Clinic of Barcelona.
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DATA ANALYSIS
In each recording, we measured onset latency at the time that
the EMG activity became consistently more than 10% above
background amplitude, whether at rest or during contraction.
Amplitude was measured from the maximum negative peak to
the maximum positive peak. Total MEP duration was measured
from MEP onset latency to the time at which the activity
returned to baseline. We determined the percentage change
for each MEP parameter during contraction with respect to
rest. For the statistical comparison among groups, we chose
to analyze the recordings from the dominant side in healthy
subjects and the most impaired side in patients. In the 10
newly recruited subjects, we examined the effects of level of
muscle contraction (mild and strong) on the MEP onset latency,
peak-to-peak amplitude, and duration. We compared also the
effects of cortical to those of foraminal stimulation. The outcome
measure in which we focused our study was the increase in
duration that takes place during contraction at the tail of the
MEP (tail), as a specific aspect of MEP facilitation. This was
measured in ms as the difference between the end of the MEP
obtained during contraction and the end of the MEP obtained
at rest.
All data were analyzed using SPSS 21.0 (IBM UK, London).
We used repeated measures ANOVA for the analysis of the
effects of level of muscle contraction in healthy subjects (rest,
mild contraction and strong contraction). A One-way analysis
of variance (ANOVA) was used to determine whether there
were significant differences in retrospective data among the three
independent groups with a sizeable number of subjects (healthy
controls, multiple sclerosis, and stroke patients). In the other 2
groups of patients (HSP and psychogenic patients) the sample
was too small to do the analyses. P ≤ 0.05 was considered
statistically significant.
RESULTS
The newly recruited subjects were 5 men and 5 women, with an
age ranging from 32 to 65 (44 ± 7). In the subjects recruited
retrospectively, mean age was significantly higher in patients with
stroke than in the other groups (Table 1). Data were available
from all subjects initially recruited, with no data gaps or missing
information.
TABLE 1 | Demographic and general clinical characteristics of patients
included in the retrospective study.
Stroke MS HSP Psychogenic
Age 67 (6.4)a 52 (3.1) 49 (4.3) 54 (2.4)
Gender (M/F) 21/12 11/10 4/1 5/0
Weakness (MCR) 1–4 2–5 4–5* 0–3**
Most imparied side 14 R/19 L 14 R/7 L Bilateral* 4R/1L
asignificantly higher than in the other groups.
*In leg muscles.
**As for the patients first expression, with no encouragement.
MEPs from the FDI to Cortical and
Foraminal Stimulation in Healthy Subjects
Representative examples of recordings in one of the newly
recruited healthy subject are shown in Figure 1 to cortical and
foraminal stimulation. A summary of the mean data is reported
in Table 2. The effects of contraction on the MEP elicited
with cortical stimulation were the expected ones: shortening of
onset latency, increase in amplitude and increase in duration.
The repeated measures ANOVA for values obtained when
comparing the three conditions (rest, mild contraction, and
strong contraction) showed statistically significant differences
[ANOVA; F(2, 27) = 4.981; p = 0.004]. The post-hoc
analysis showed that all significant differences were found when
comparing contraction to rest (p < 0.05 for latency, amplitude
and duration), but there were no significant differences between
data obtained with mild and strong contraction (p > 0.05
for all comparisons). The MEP tail increased a mean of 4.1ms
(SD = 0.8ms) with mild contraction and 4.4ms (SD = 0.5ms)
with strong contraction (p > 0.05). With foraminal stimulation
there were no significant changes in onset latency, amplitude or
duration, although amplitude, and duration increased in a few
trials in some subjects (Table 2). A burst was consistently seen
at a mean latency of 38.7ms (SD = 5.1ms), interrupting the
post-MEP silent period.
Comparison of Data among Groups
Table 3 shows the summary of retrospective data gathered for
all groups on the MEP at rest and during contraction as well as
the percentage change observed during contraction with respect
to rest for onset latency, peak amplitude and MEP duration.
Representative recordings ofMEPs at rest and during contraction
are shown in Figure 2 for the FDI recordings in each group
FIGURE 1 | MEPs in healthy control subjects at rest and during
contraction, recorded in the first dorsal interosseous muscle to
cortical stimulation (above) and cervical foraminal stimulation (below).
Rest, Recorded at rest; Contr, Recorded during contraction. The vertical lines
illustrate the methods used to measure the MEP tail as one of the aspects of
MEP facilitation with contraction.
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of patients. There were already significant differences among
groups in the characteristics of the MEPs recorded at rest. The
repeatedmeasures one-factor ANOVA, run only on data from the
three groups with a sizeable number of subjects (healthy subjects,
stroke, and MS patients), showed significant differences in onset
latency, peak amplitude, and MEP duration [F(2, 76); p < 0.01 for
all of them]. The post-hoc analyses showed that patients with MS
and stroke had delayed onset latency and smaller peak amplitude
than healthy subjects (p < 0.05 for both groups of patients in
both comparisons). In regard to MEP duration, patients with MS
had a significantly longer duration, while patients with stroke
had significantly shorter duration, than the other two groups
(p < 0.005 for all comparisons).
Muscle contraction induced facilitation to different degrees
in healthy subjects and patients (Table 3). As expected, the
TABLE 2 | Data gathered from 10 newly recruited healthy volunteers on
facilitation of the MEP with mild and strong voluntary muscle
contractions.
Rest Mild % Strong %
CORTICAL STIMULATION
Onset latency (ms) 21.5 (1.8) 19.7 (1.3)* 91.6 19.6 (1.1)* 91.1
Amplitude (mV) 1.1 (0.6) 4.1 (0.7)* 372.7 4.4 (0.9)* 401.0
Duration (ms) 12.7 (2.0) 17.7 (3.3)a 139.3 17.9 (3.9)* 140.9
FORAMINAL STIMULATION
Onset latency (ms) 13.4 (1.1) 13.3 (1.1) 99.2 13.3 (1.0) 99.2
Amplitude (mV) 0.9 (0.5) 1.3 (0.6)* 144.4 1.3 (0.7)* 144.6
Duration (ms) 8.4 (1.7) 8.8 (2.1) 104.7 8.8 (2.2) 104.8
Data are represented as mean and 1 standard deviation (within parenthesis). Data in
the columns labeled % are the ratio between contraction and rest for mild and strong
contractions. Asterisks refer to a significant difference (p < 0.05) with respect to rest, in
the post-hoc analysis after one factor ANOVA.
percentage shortening in onset latency, increase in peak
amplitude, and lengthening in MEP duration, including the
increase in MEP tail, calculated in healthy subjects were all
similar to those reported above on the newly recruited subjects.
The effects of contraction on the MEP in patients were not
uniform, and the percentage change with respect to rest showed
significant differences in all comparisons [ANOVA; F(2, 76); p <
0.05]. The post-hoc analyses indicated a significantly bigger
percentage of onset latency shortening, and a significantly larger
percentage of peak amplitude increase, in stroke than in MS
patients. In MEP duration, differences were found between
groups in all comparisons: There was a smaller increase in MS
patients than in healthy subjects and stroke patients, and a bigger
increase in stroke patients than in healthy subjects and MS
patients (p < 0.05 for all comparisons). No significant differences
with respect to healthy subjects were observed in hand muscles
in patients with HSP but they were observed in leg muscles
(reported below). In patients with psychogenic weakness, MEP
duration was similar at rest and during voluntary contraction,
although a moderate shortening of latency and increase in
amplitude was observed in some traces.
A more striking difference among groups was observed in the
MEP tail (Table 4). The contraction-induced increase in MEP
duration beyond the end of the MEP at rest was significantly
different among most groups, including psychogenic patients, in
the FDI.
MEPs from the Tibialis Anterior
Data were gathered from 12 healthy subjects and the 5 patients
with HSP. Although we did not run comparative statistics
because of the small number of subjects, differences between
the two groups of subjects were already clear at rest (Table 3)
and more so in the percentage increase of MEP duration with
voluntary contraction. ThemeanMEP tail increase was markedly
TABLE 3 | Mean data on MEPs obtained at rest in the healthy subjects and patients included in the retrospective study.
Onset latency Percentage Peak amplitude Percentage MEP duration Percentage
Rest Contr Rest Contr Rest Contr
HV (25) 21.3 (1.9) 19.2 (1.4) 90.14 3.1 (0.7) 6.8 (2.7) 219.35 13.1 (2.3) 17.8 (2.3) 135.88
Stroke (33) 23.6 (3.1)a 20.5 (2.2) 86.86 0.7 (1.3)b 2.2 (3.1)b 307.14 9.3 (4.8)b 18.2 (3.1) 195.70a
MS (21) 25.5 (4.2)a 24.5 (3.3)a 96.08c 1.4 (0.8)b 1.9 (2.2)b 135.71d 19.4 (2.5)a,d 21.7 (3.7) 111.86d
Psychogenic (5) 21.1 (2.2) 20.3 (3.0) 96.21 1.7 (2.3) 2.3 (3.5) 135.29 14.0 (2.1) 14.3 (2.3) 102.14
HSP (5) 22.0 (3.1) 19.9 (2.8) 90.45 2.3 (1.5) 4.8 (3.0) 208.70 14.5 (2.9) 19.1 (4.1) 131.72
HV TA (12) 30.9 (2.8) 28.5 (2.0) 92.23 1.4 (1.0) 2.9 (2.3) 207.14 19.7 (4.5) 29.4 (5.6) 144.16
HSP TA (5) 35.8 (4.7) 35.4 (4.1) 98.88 0.5 (1.2) 0.6 (1.8) 115.38 35.9 (8.4) 36.2 (9.9) 100.83
Data are the mean and one standard deviation (within parenthesis) measured on the MEP recorded in the first dorsal interosseous (except for HV TA and HSP TA, which were recorded
in the tibialis anterior). HV, Healthy volunteers; MS, Multiple sclerosis; HSP, Hereditary spastic paraparesis. The number in parenthesis in the first column refers to the number of patients
included in the analysis.
Onset latency and duration aremeasured inms; peak amplitude inmV. Percentage refers to the percentage of theMEP characteristics during contraction with respect to rest. Superindices
a, b, and c refer to significant differences (p < 0.05) found in the comparison among the three groups with a sizeable sample (healthy subjects, patients with stroke, and patients with
multiple sclerosis).
aSignificantly longer than in healthy subjects.
bSignificantly shorter than in healthy subjects.
cSignificantly longer/larger in MS than in stroke.
dSignificantly smaller/shorter in MS than in stroke.
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FIGURE 2 | Examples of MEP recordings in first dorsal interosseous at
rest and during contraction in multiple sclerosis patients (A), stroke
patients (B), and psychogenic weakness patients (C).
TABLE 4 | Differences in MEP tail among groups of subjects.
Recording Group (N) Increase in MEP tail
FDI Control (25) 4.7 (0.7)
MS (21) 1.4 (1.2)a
Stroke (33) 8.5 (1.8)b
Psychogenic (5) 0.8 (2.1)a
HSP (5) 4.5 (0.9)
TA Control (12) 6.1 (1.1)
HSP (5) 0.5 (0.9)a
Data are the mean calculated among all subjects of the same group. Superindices a and
b refer to the statistical significance measured with the post-hoc comparison after one-
factor ANOVA including all groups recorded in the same muscle.
aSignificantly shorter than in control subjects.
bSignificantly longer than in all other groups.
larger in healthy subjects than in patients (Table 4), with a
significant difference in the unpaired t-test (p < 0.05). Figure 3
shows representative TA recordings from healthy controls and
patients with HSP.
DISCUSSION
The main physiological mechanism for MEP facilitation is,
likely, the increase in spinal motorneuronal excitability. During
voluntary contraction, the descending volley will meet with
FIGURE 3 | MEPs recorded in the tibialis anterior muscle at rest and
during voluntary contraction in a healthy subject (A) and an HSP
patient (B).
more motoneurons available for firing than at rest (Di Lazzaro
et al., 2008). Descending volleys after cortical stimulation in
humans have been recorded with epidural electrodes (Di Lazzaro
et al., 1999). While a direct (D) wave can be obtained with
electrical stimulation, this is usually not so with TMS (Day
et al., 1987; Di Lazzaro et al., 1999), where mostly indirect
(I) waves are recorded. The I waves have an interpeak latency
of about 1.2–2.0ms, up to about 6ms after the D wave (Day
et al., 1987; Boniface et al., 1991; Nakamura et al., 1997). The
ultimate target of such descending volleys is assumedly the
alpha motorneuron, but an unknown number of excitatory and
inhibitory propriospinal interneurons may lay in between. The
number of descending I waves increases little when subjects
perform a voluntary contraction (Di Lazzaro et al., 1999).
Therefore, the large increase in the MEP duration reveals that
facilitation takes place mostly because of summation of inputs
from various sources at the alpha motorneuronal level.
Polyphasic MEPs have been reported so far in various
diseases. In patients with ALS (Kohara et al., 1999), the
authors suggested that polyphasic MEPs were due to activation
of additional motor pathways, such as slow monosynaptic
pyramidal or even polysynaptic pathways in ALS patients. In
patients with DYT11-positive myoclonus-dystonia syndrome
(van der Salm et al., 2009), the authors hypothesized that the
mutation associated with the disease, SGCE gene, could have
caused changes in membrane properties or ion channels, leading
to asynchronous discharge timing of spinal motorneurons
by the descending corticospinal activity. MEP polyphasia has
been also reported in MS, who have already an increase
in MEP duration at rest (Kukowski, 1993), compatible with
Frontiers in Neuroscience | www.frontiersin.org 5 January 2016 | Volume 9 | Article 505
Brum et al. Clinical Value of MEP Duration Analysis
increased temporal dispersion of the impulses reaching the spinal
motorneurons. Recently, in patients with idiopathic generalized
epilepsy (IGE) and first-degree relatives, Chowdhury et al. (2015)
showed increased polyphasia, attributed to abnormal timing and
patterning of the descending volleys in the corticospinal tract,
and suggested that this was a novel endophenotype in this
pathology. No data are available on changes in MEP duration in
patients so far and, specifically in the increase in the MEP tail,
beyond the end of the MEP at rest. We found that this parameter
was the one discriminating better among our groups of subjects.
Patients with MS and HSP had longer duration of MEP
already at rest, with little increase during contraction. In
patients with stroke, if their damaged corticospinal tract was
still excitable, the MEP increased significantly in amplitude and
duration, indicating preservation of spinal mechanisms involved
in contraction-induced facilitation. The only group studied in
which we found no increase in duration was in the patients
with psychogenic weakness. This was probably due to voluntary
absence of energization of alpha motorneurons by these patients.
The mechanisms involved in the increase in MEP duration
with muscle contraction are not clear but our results are
consistent with a role for the excitatory pre-motor interneurons
that are activated by descending inputs from contralateral
corticospinal tract. Patients with MS and HSP, with lesions
in the spinal cord, had increased duration at rest likely
because of dispersion of the descending volley reaching
the alpha motorneuron. These patients could not increase
the synchronization of their motorneuronal firing, and the
possible implication of the interneurons is masked by the
already long duration of the MEP. In patients with stroke,
whose spinal interneurons are not altered, the mechanisms of
contraction-induced facilitation are fully activated, provided that
the volley reaches the spinal level. In opposition, patients with
psychogenic weakness do not perform the maximum voluntary
contraction when requested, and may not set their spinal
interneurons excitability at the level required for facilitation of
the MEP during contraction.
The main limitation of our study is that it is retrospective
and, therefore, it was not specifically designed for the study
of the effects of duration. Even though the data reported here
were generated after standardized recordings with no missing
values, replication of the study is needed before firm conclusions.
Meanwhile, we can conclude that the increase in duration of
the MEP during contraction beyond the end of the resting MEP
may reveal the activation of premotor propriospinal interneurons
by descending inputs. This mechanism may be altered in
some diseases. The patterns of MEP facilitation with voluntary
contraction may differ depending on the disease, and the study
of this feature can be of some clinical utility in the differential
diagnosis of weakness.
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